Aperbio leverages advanced digital PCR (dPCR) and quantitative PCR (qPCR) technology platforms, along with ultra-multiplex detection capabilities, to provide comprehensive solutions for Sepsis detection, pathogen detection, disease surveillance, and research.These advancements support precision medicine and enhance public health prevention and control efforts.